S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q3 2025

BVF Partners

Period: Q3 2025 Β· Filed: 2025-11-14
View on SEC EDGAR β†—
AUM
$2.47B
Total portfolio value
Positions
46
Reported securities
Top Holding
KYMR
12.6% $311.4M
QoQ Changes
+7 / -5
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
KYMRKYMERA THERAPEUTICS INC$311.4M12.63%$56.60$113.51+100.5%
12.6%
RVMDREVOLUTION MEDICINES INC$185.6M7.52%$46.70$189.24+305.2%
7.5%
PTGXPROTAGONIST THERAPEUTICS INC$170.1M6.90%$66.43$131.62+98.1%
6.9%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$141.6M5.74%$7.17$18.95+164.3%
5.7%
CDTXCIDARA THERAPEUTICS INC$135.4M5.49%β€”β€”
5.5%
GHRSGH RESEARCH PLC$126.2M5.12%$14.30$27.01+88.9%
5.1%
MIRMMIRUM PHARMACEUTICALS INC$109.6M4.44%$73.31$125.59+71.3%
4.4%
XOMAXOMA ROYALTY CORPORATION$99.8M4.05%$38.54$43.00+11.6%
4.0%
GPCRSTRUCTURE THERAPEUTICS INC$89.7M3.64%$28.00$53.45+90.9%
3.6%
KURAKURA ONCOLOGY INC$76.3M3.09%$8.85$11.10+25.4%
3.1%
SEPNSEPTERNA INC$75.5M3.06%$18.81$34.00+80.8%
3.1%
PVLAPALVELLA THERAPEUTICS INC NE$72.8M2.95%$62.69$146.76+134.1%
3.0%
NKTRNEKTAR THERAPEUTICS$72.6M2.94%$56.90$71.04+24.9%
2.9%
ZYMEZYMEWORKS INC$67.3M2.73%$17.08$26.31+54.0%
2.7%
AXSMAXSOME THERAPEUTICS INC$59.1M2.40%$121.45$244.31+101.2%
2.4%
ACIUAC IMMUNE SA$57.3M2.32%$2.89$2.51-13.2%
2.3%
IMCRIMMUNOCORE HLDGS PLC$57.2M2.32%$36.33$32.50-10.5%
2.3%
OLMAOLEMA PHARMACEUTICALS INC$51.9M2.10%$9.79$12.64+29.1%
2.1%
TYRATYRA BIOSCIENCES INC$51.1M2.07%$13.99$30.62+118.9%
2.1%
ABVXABIVAX SA$47.4M1.92%$84.90$144.65+70.4%
1.9%
GLUEMONTE ROSA THERAPEUTICS INC$41.9M1.70%$7.41$24.21+226.7%
1.7%
FDMT4D MOLECULAR THERAPEUTICS IN$40.2M1.63%$8.69$13.00+49.6%
1.6%
STOKSTOKE THERAPEUTICS INC$38.9M1.58%$23.50$32.70+39.1%
1.6%
CGEMCULLINAN THERAPEUTICS INC$34.1M1.38%$5.93$17.63+197.3%
1.4%
CELCCELCUITY INC$32.5M1.32%$49.40$107.95+118.5%
1.3%
XNCRXENCOR INC$32.1M1.30%$11.73$15.00+27.9%
1.3%
FHTXFOGHORN THERAPEUTICS INC$25.9M1.05%$4.89$5.30+8.4%
1.1%
ANNXANNEXON INC$21.4M0.87%$3.05$5.46+79.0%
0.9%
RPTXREPARE THERAPEUTICS INC$18.2M0.74%β€”β€”
0.7%
AVTXAVALO THERAPEUTICS INC$17.2M0.70%$12.71$18.84+48.2%
0.7%

Quarter-on-Quarter Activity

Q3 2025 vs. Q2 2025

New Positions (7)

TickerIssuerNotionalSince Filing
NKTRNEKTAR THERAPEUTICS$72.6M+24.9%
ABVXABIVAX SA$47.4M+70.4%
STOKSTOKE THERAPEUTICS INC$38.9M+39.1%
CMPXCOMPASS THERAPEUTICS INC$16.6M
PEPGPEPGEN INC$8.8M
XFORX4 PHARMACEUTICALS INC$7.6M
IMAIMAGENEBIO INC$6.5M

Exited Positions (5)

TickerIssuerNotional
IONSIONIS PHARMACEUTICALS INC$75.6M
VSTMVERASTEM INC$14.1M
RAPTRAPT THERAPEUTICS INC$9.2M
IKNAIKENA ONCOLOGY INC$5.4M
OVIDOVID THERAPEUTICS INC$1.3M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
GPCRSTRUCTURE THERAPEUTICS INC$53.0M+80.9%+90.9%
CDTXCIDARA THERAPEUTICS INC$97.1M+79.8%
PVLAPALVELLA THERAPEUTICS INC NE$57.1M+66.7%+134.1%
IMCRIMMUNOCORE HLDGS PLC$25.1M+53.7%-10.5%
EPIXESSA PHARMA INC$-12.6M+33.4%
AVTXAVALO THERAPEUTICS INC$12.1M+31.8%+48.2%
KURAKURA ONCOLOGY INC$31.5M+11.1%+25.4%
SABSSAB BIOTHERAPEUTICS INC$0.3M+1.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
FBRXFORTE BIOSCIENCES INC$-6.6M-88.9%
CELCCELCUITY INC$-13.8M-81.0%+118.5%
AXSMAXSOME THERAPEUTICS INC$-117.3M-71.2%+101.2%
MIRMMIRUM PHARMACEUTICALS INC$-30.9M-45.8%+71.3%
PTGXPROTAGONIST THERAPEUTICS INC$-7.3M-20.2%+98.1%
RVMDREVOLUTION MEDICINES INC$2.3M-20.2%+305.2%
SEPNSEPTERNA INC$29.1M-8.7%+80.8%
ZYMEZYMEWORKS INC$13.2M-8.6%+54.0%
← Back to Hedge Funds